Qsemble Capital Management LP Reduces Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Qsemble Capital Management LP reduced its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 70.1% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,355 shares of the company's stock after selling 7,852 shares during the quarter. Qsemble Capital Management LP's holdings in Ryan Specialty were worth $223,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of RYAN. Signaturefd LLC lifted its holdings in shares of Ryan Specialty by 12.3% during the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company's stock worth $89,000 after acquiring an additional 148 shares during the period. UMB Bank n.a. boosted its holdings in shares of Ryan Specialty by 5.2% in the 3rd quarter. UMB Bank n.a. now owns 5,224 shares of the company's stock valued at $347,000 after purchasing an additional 256 shares in the last quarter. Loomis Sayles & Co. L P raised its holdings in shares of Ryan Specialty by 26.3% during the 3rd quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company's stock worth $91,000 after buying an additional 286 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of Ryan Specialty by 96.4% during the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company's stock worth $35,000 after buying an additional 297 shares in the last quarter. Finally, Hollencrest Capital Management acquired a new stake in Ryan Specialty in the third quarter valued at about $25,000. Institutional investors own 84.82% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on RYAN shares. Barclays increased their target price on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an "overweight" rating in a report on Thursday, November 21st. JPMorgan Chase & Co. boosted their target price on shares of Ryan Specialty from $54.00 to $56.00 and gave the stock an "underweight" rating in a research note on Friday, August 2nd. BMO Capital Markets raised Ryan Specialty from a "market perform" rating to an "outperform" rating and raised their price objective for the company from $65.00 to $75.00 in a report on Tuesday, September 24th. UBS Group increased their target price on Ryan Specialty from $67.00 to $76.00 and gave the company a "buy" rating in a research report on Tuesday, August 13th. Finally, Wells Fargo & Company upped their price objective on Ryan Specialty from $63.00 to $70.00 and gave the company an "equal weight" rating in a research note on Thursday, October 10th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $71.67.

Ryan Specialty Price Performance

RYAN stock opened at $75.10 on Thursday. The company's fifty day simple moving average is $69.50 and its 200 day simple moving average is $62.95. Ryan Specialty Holdings, Inc. has a 12-month low of $41.49 and a 12-month high of $75.86. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm has a market cap of $19.66 billion, a price-to-earnings ratio of 97.53, a PEG ratio of 1.69 and a beta of 0.62.

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.41. The company had revenue of $604.69 million for the quarter, compared to the consensus estimate of $602.04 million. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. Ryan Specialty's quarterly revenue was up 20.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.32 EPS. On average, analysts expect that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current year.

Ryan Specialty Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were paid a $0.11 dividend. The ex-dividend date was Tuesday, November 12th. This represents a $0.44 annualized dividend and a dividend yield of 0.59%. Ryan Specialty's dividend payout ratio is presently 57.14%.

Insider Activity at Ryan Specialty

In related news, Director David P. Bolger sold 7,055 shares of the firm's stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $70.88, for a total transaction of $500,058.40. Following the transaction, the director now directly owns 78,149 shares of the company's stock, valued at $5,539,201.12. This trade represents a 8.28 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Mark Stephen Katz sold 14,790 shares of the firm's stock in a transaction on Friday, November 8th. The shares were sold at an average price of $71.39, for a total value of $1,055,858.10. Following the sale, the executive vice president now directly owns 12,386 shares of the company's stock, valued at approximately $884,236.54. This represents a 54.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by corporate insiders.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.